We are live on ! Find out more
Stanley Druckenmiller

Stanley Druckenmiller Duquesne Family Office

AUM $3.38B
1-Year Est. Return 61.92%
 

Stanley Druckenmiller is the founder of Duquesne Family Office and one of the most closely watched macro investors of his generation. He first became widely known as lead portfolio manager of the Quantum Fund alongside George Soros, including during the famous 1992 bet against the British pound. After returning outside capital, he has continued to invest with a flexible, top-down approach that blends macroeconomic views with concentrated equity and commodity positions.

This Fund
S&P 500
This Quarter Est. Return
+21.41%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$4.07B
AUM Growth
+$1.01B
Cap. Flow
+$339M
Cap. Flow %
8.33%
Top 10 Hldgs %
50.54%
Holding
87
New
35
Increased
13
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
ENTG icon
Entegris
ENTG
+$125M
2
MSFT icon
Microsoft
MSFT
+$87.3M
3
INSM icon
Insmed
INSM
+$67.6M
4
WBD icon
Warner Bros
WBD
+$61M
5
QSR icon
Restaurant Brands International
QSR
+$50.2M

Top Sells

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$133M
2
COHR icon
Coherent
COHR
+$76.6M
3
WWD icon
Woodward
WWD
+$50.9M
4
PM icon
Philip Morris
PM
+$49.7M
5
NTRA icon
Natera
NTRA
+$49.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Technology 20.5%
3 Consumer Discretionary 13.73%
4 Industrials 10.55%
5 Financials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHYM
51
Chime Financial
CHYM
$11.9B
$16.1M 0.4%
+466,825
New +$15.4M
BMA icon
52
Banco Macro
BMA
$5.51B
$15.5M 0.38%
220,900
-210,915
-49% -$17.4M
NAMS icon
53
NewAmsterdam Pharma
NAMS
$3.23B
$15.1M 0.37%
832,175
+31,815
+4% +$580K
VKTX icon
54
Viking Therapeutics
VKTX
$3.88B
$14.6M 0.36%
+549,295
New +$14.5M
GGAL icon
55
Galicia Financial Group
GGAL
$7.51B
$11.7M 0.29%
231,481
-150,000
-39% -$8.59M
BWXT icon
56
BWX Technologies
BWXT
$15.3B
$11M 0.27%
+76,475
New +$8.93M
INSM icon
57
CALL
Insmed
INSM
$28.7B
$10.1M 0.25%
+100,000
New +$7.65M
TBBB icon
58
BBB Foods
TBBB
$4.9B
$10M 0.25%
+360,550
New +$10.1M
DHI icon
59
D.R. Horton
DHI
$40.8B
$9.98M 0.25%
+77,400
New +$9.53M
LEN icon
60
Lennar Class A
LEN
$20.4B
$9.94M 0.24%
+89,900
New +$9.74M
BLDR icon
61
Builders FirstSource
BLDR
$7.8B
$9.93M 0.24%
+85,065
New +$9.82M
FCX icon
62
Freeport-McMoran
FCX
$95.5B
$9.74M 0.24%
224,800
-793,305
-78% -$30.1M
CCC
63
CCC Intelligent Solutions
CCC
$3.83B
$9.48M 0.23%
1,007,944
-4,587,095
-82% -$41M
ELVN icon
64
Enliven Therapeutics
ELVN
$4.31B
$9.29M 0.23%
+463,000
New +$8.77M
ESLT icon
65
Elbit Systems
ESLT
$40.2B
$8.22M 0.2%
+18,287
New +$7.42M
TMO icon
66
Thermo Fisher Scientific
TMO
$214B
$4.95M 0.12%
+12,200
New +$5.1M
DHR icon
67
Danaher
DHR
$141B
$4.88M 0.12%
+24,700
New +$4.79M
CC icon
68
Chemours
CC
$2.27B
$4.83M 0.12%
+421,800
New +$4.75M
JOBY icon
69
Joby Aviation
JOBY
$8.1B
$332K 0.01%
31,489
– –
AAL icon
70
American Airlines Group
AAL
$10.6B
– –
-133,728
Closed -$1.41M
AMZN icon
71
Amazon
AMZN
$2.94T
– –
-136,765
Closed -$26M
AR icon
72
Antero Resources
AR
$10.7B
– –
-258,400
Closed -$10.4M
ASND icon
73
Ascendis Pharma A/S
ASND
$16.4B
– –
-158,720
Closed -$24.7M
BBIO icon
74
BridgeBio Pharma
BBIO
$16.2B
– –
-438,050
Closed -$15.1M
BN icon
75
Brookfield
BN
$108B
– –
-473,888
Closed -$16.6M
1 2
3
4

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Stanley Druckenmiller's Q2 2025 Portfolio in Review

As of Q2 2025, Stanley Druckenmiller held 87 positions worth $4.07B, up 33% from $3.06B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Stanley Druckenmiller deployed $339M of net new capital in Q2 2025, opening 35 new positions and adding to 13 existing holdings. Its largest new stake was Entegris: 1,645,885 shares worth $133M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Coupang, an estimated $133M trimmed.

  • Stanley Druckenmiller's largest Q2 2025 buy was Entegris: 1,645,885 shares worth $133M.
  • Stanley Druckenmiller added most to Insmed in Q2 2025, an estimated $67.6M increase.
  • Stanley Druckenmiller's biggest Q2 2025 reduction was Coupang, cutting an estimated $133M.
  • Stanley Druckenmiller fully exited Capital One in Q2 2025, selling an estimated $35.4M.
  • Stanley Druckenmiller's ten largest holdings make up 51% of its $4.07B portfolio in Q2 2025.
  • Stanley Druckenmiller opened 35 new positions and closed 18 in Q2 2025.
  • Stanley Druckenmiller's portfolio value rose 33% quarter-over-quarter to $4.07B.

Based on Duquesne Family Office's 13F filing for Q2 2025, filed 15 Aug 2025.